Haven't used Mabworks yet?
Ask Trustburn

Questions about Mabworks

Based on 8 reviews, listing data and website checks · updated 2 days ago

What is Mabworks?

Mabworks is Beijing Mabworks Biotech, a gene engineering mAb company based in Beijing, China, that develops innovative antibody drugs for autoimmune diseases and tumors. The company is known for its core product, BeiJieXin® (obinutuzumab beta), and is developing clinical candidates like MIL60, MIL62, and MIL116. It operates from facilities in Beijing Economic-Technological Development Area and Beijing Daxing Biomedical Base.

What makes Mabworks different from competitors?

The company's unique ADCC enhancement antibody platform uses glycosylation modification to increase NK cell activation, distinguishing it from standard CD20 monoclonal antibodies. Their multi-specificity platform allows for simultaneous binding to different targets, while their long-acting platform optimizes pharmacokinetics to extend dosing intervals. These proprietary technologies enable the design and development of best-in-class in研 drugs from discovery to development.

What products or services does Mabworks offer?

BeiJieXin® is a third-generation CD20 antibody approved in China for treating neuromyelitis optica spectrum disorder (NMOSD) and primary membranous nephropathy (pMN). It is the world's first drug approved for pMN and the first domestic drug approved for NMOSD. The company also has MBS303, MBS314, and MIL116 in various clinical stages for kidney and blood diseases.

How long has Mabworks existed and how is it structured?

Mabworks has been operating since at least 2009, as indicated by its ICP filing number 京ICP备 09113705 号. The company has a diverse team structure with roles in R&D, production, commercialization, and partnerships, including collaborations with global and Chinese pharmaceutical leaders.

Who is Mabworks for?

The company is primarily for patients suffering from autoimmune diseases such as NMOSD and pMN, as well as those with tumors like multiple myeloma and IgA nephropathy. It also serves healthcare professionals and researchers looking for innovative antibody therapies and clinical trial data.

What do reviewers praise about Mabworks?

Reviewers consistently praise Mabworks for having a highly skilled, professional, and efficient team that delivers exceptional results. They also commend the user-friendly nature of the company website, which provides all necessary information and is easy to navigate.

What do news articles say about Mabworks?

News articles from 2026 highlight Mabworks' partnership with Climb Bio, demonstrating deep APRIL suppression and significant Gd-IgA1 reduction in clinical trials. This collaboration supports the development of long-acting antibodies for IgA nephropathy, with Phase 3 trials expected to initiate in 2027.

What specific features does the multi-specificity platform offer?

The company's multi-specificity antibody platform enables the development of drugs like MBS314, a GPRC5D/BCMA/CD3 tri-specific antibody designed to provide a potentially better solution for multiple myeloma patients.

How does the long-acting antibody platform work?

The long-acting antibody platform integrates advanced antibody engineering techniques to optimize pharmacokinetic properties, aiming to achieve longer dosing intervals and improve patient compliance in disease treatment.

What does the antibody discovery and optimization platform do?

The antibody discovery and optimization platform is designed to identify and optimize highly effective and low-toxicity candidate antibodies, ensuring a robust pipeline of potential best-in-class drugs.

How does the drug development process work?

The process involves using proprietary platforms to design, evaluate, and select the best in研 drugs from discovery through development, leveraging glycosylation modification and multi-specificity to achieve deep B-cell clearance and sustained disease control.

What is the official website of Mabworks?

The official website of Mabworks is mab-works.com.

How is Mabworks rated on Trustburn?

On Trustburn, Mabworks has a rating of 3.9 out of 5 based on 8 reviews.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Sabine Teufel
Reviews 1

I'm so pleased with the services provided by Mabworks. They have a highly skilled team that delivers exceptional results. The company website, mab-works.com, is user-friendly and provides all the necessary information. I highly recommend Mabworks for all your business needs. 👍

Sean Chiappetta
Reviews 1

👍 I am extremely happy with the services provided by Mabworks. They go above and beyond to ensure customer satisfaction. The team is highly skilled and professional. I have been consistently impressed with their work. The company website, mab-works.com, is easy to navigate and provides all the necessary information. I highly recommend Mabworks for all your business needs!

Uri Yaffe
Reviews 1

👏 I am extremely impressed with the services provided by Mabworks. Their team is highly skilled, professional, and efficient. I have been using their services for a while now and I am very satisfied with the quality of their work. The company website, mab-works.com, is user-friendly and provides all the necessary information. I highly recommend Mabworks to anyone in need of reliable and trustworthy services.

Kathy Prickett
Reviews 1

I recently had the pleasure of working with Mabworks and I must say, their services are outstanding. The team is highly skilled, professional, and dedicated to delivering exceptional results. The company website, mab-works.com, provides all the necessary information and is easy to navigate. I would highly recommend Mabworks for all your business needs.

Satyendra Singh
Reviews 1

I recently availed the services of a company. I must say, their work is commendable. The team at Mabworks is efficient and delivers high-quality results. I appreciate their professionalism and attention to detail. They have helped me achieve great success in my projects. I would like to express my gratitude towards the company for their outstanding services.

Greg Furman
Reviews 1

The services provided by Mabworks are excellent. They have a highly skilled and experienced team that delivers top-notch results. I have been using their services for quite some time now and I am extremely satisfied with the quality of their work. The company website, mab-works.com, is user-friendly and easy to navigate. I highly recommend Mabworks to anyone in need of professional services.

Daniel Vallance
Reviews 1

I recently used the services of a company and I am very satisfied with the results. The team at Mabworks is highly efficient and professional. They catered to all my requirements and delivered excellent work. I appreciate their attention to detail and commitment to customer satisfaction. Mabworks is definitely my go-to company for all my future projects.

Kevin Cassady
Reviews 1

Mabworks is an excellent company. Their services are top-notch and their team is highly skilled. I have been working with them for a while now and I am thoroughly impressed with their professionalism and dedication. The company website is user-friendly and provides all the necessary information. I highly recommend Mabworks to anyone in need of reliable services.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="mab-works-com" data-lang="en"></div>
More widgets

About Mabworks

Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.